Skip to main content
. 2021 Jan 18;12(6):1698–1707. doi: 10.7150/jca.40500

Table 1.

Expression of MLH1, PMS2, MSH2 and MSH6 and microsatellite status in GC.

MLH1 PMS2 MSH2 MSH6 Samples (%) MSI status sum
+ + + + 169 (78.6) MSS 169
- + + + 6 (2.8) MSI 46
+ - + + 22 (10.2)
+ + - + 1 (0.5)
+ + + - 7 (3.3)
- - + + 10 (4.6)

GC, gastric cancer; MSI, microsatellite instability; MSS, microsatellite stability. MLH1, PMS2, MSH2 and MSH6 immunohistochemical evaluations were completed in all 215 cases.